関節痛用注射のグローバル市場(2022年-2029年):インターロイキン阻害剤、ヒアルロン酸注射

■ 英語タイトル:Global Joint Pain Injections Market Size study & Forecast, by Injection Type (Interleukin Inhibitors, Hyaluronic Acid Injections), by Joint Type (Knee and Ankle, Hip Joint, Shoulder and Elbow, Facet Joints of the Spine), by Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート(データ管理コード:BZW23FE0009)■ 発行会社/調査会社:Bizwit Research & Consulting
■ 商品コード:BZW23FE0009
■ 発行日:2023年2月8日
■ 調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野:医療
■ ページ数:約200
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥752,400見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥950,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[関節痛用注射のグローバル市場(2022年-2029年):インターロイキン阻害剤、ヒアルロン酸注射]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Bizwit Research社の本調査資料では、2021年に63億ドルであった世界の関節痛用注射市場規模が、2022年〜2029年にかけて7.7%で成長すると予測しています。本資料は、関節痛用注射の世界市場について市場実態を明らかにするとともに、今後の動向を展望したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、注射種類別(インターロイキン阻害剤、ヒアルロン酸注射)分析、関節別(膝・足首関節、股関節、肩・肘関節、椎間関節)分析、流通チャネル別(病院薬局、ドラッグストア・小売薬局、オンラインプロバイダ)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他)分析、競争分析、調査プロセスなどの項目で構成されています。また、主要参入企業として、Abbvie Inc. 、Anika Therapeutics、 Bioventus、 Eli Lilly and Company、 Ferring Pharmaceuticals Inc.、 PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.)、 Pfizer Inc.、 Sanofi S.A.、 Teva Pharmaceuticals、 Zimmer Biometなどの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の関節痛用注射市場規模:注射種類別
- インターロイキン阻害剤の市場規模
- ヒアルロン酸注射の市場規模
・世界の関節痛用注射市場規模:関節別
- 膝・足首関節用注射の市場規模
- 股関節用注射の市場規模
- 肩・肘関節用注射の市場規模
- 椎間関節用注射の市場規模
・世界の関節痛用注射市場規模:流通チャネル別
- 病院薬局チャネルの市場規模
- ドラッグストア・小売薬局チャネルの市場規模
- オンラインプロバイダチャネルの市場規模
・世界の関節痛用注射市場規模:地域別
- 北米の関節痛用注射市場規模
- ヨーロッパの関節痛用注射市場規模
- アジア太平洋の関節痛用注射市場規模
- 中南米の関節痛用注射市場規模
- その他地域の関節痛用注射市場規模
・競争分析
・調査プロセス

Global Joint Pain Injections Market is valued approximately USD 6.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2022-2029. Arthritis injections are given directly into the joints to relieve pain and minimize inflammation and swelling. Joint pain usually occurs in the elderly as a result of pre-existing diseases or conditions. Arthritis is a common disease that mainly occurs in the knee, ankle, hip, shoulder, elbow, and facet joints of the spine, causing joint pain that causes inflammation and increases joint discomfort. The increasing prevalence of osteoarthritis and rheumatoid arthritis and growing need for affordable treatment solutions as well as rising rate of injuries due to accidents are key factors accelerating the market growth.

The rising prevalence of osteoarthritis and rheumatoid arthritis is contributing to the growth of the Global Joint Pain Injections Market. For instance, according to The Arthritis Foundation estimates – as of 2019, approximately more than 91 million adults in the U.S. living with arthritis, and the number is protected to reach to 113 million by 2040. Additionally, the number of adults in the U.S. with doctor-diagnosed arthritis is likely to increase to 78.4 million, and the number of individuals reporting activity limitations due to arthritis would increase to 34.6 million by 2040. Also, rising number of geriatric individuals and growing healthcare infrastructure in developing regions would create lucrative growth prospectus for the market over the forecast period. However, stringent regulatory framework for treatment approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Joint Pain Injections Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players and increasing prevalence of arthritis in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and rising expansion of contract manufacturing organizations, coupled with increasing penetration of leading market players in the region.

Major market player included in this report are:
Abbvie Inc.
Anika Therapeutics
Bioventus
Eli Lilly and Company
Ferring Pharmaceuticals Inc.
PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.)
Pfizer Inc.
Sanofi S.A.
Teva Pharmaceuticals
Zimmer Biomet
Recent Developments in the Market:
 In July 2019- Tel Aviv, Israel based Teva Pharmaceutical Industries Ltd. has launched 1% Sodium Hyaluronate in the U.S. market after receiving approval from the Center for Devices and Radiological Health of the U.S. FDA. This new product is intended for the treatment of pain associated with osteoarthritis in the knee

Global Joint Pain Injections Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Injection Type, Joint Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Injection Type
Interleukin Inhibitors
Hyaluronic Acid Injections
By Joint Type
Knee and Ankle
Hip Joint
Shoulder and Elbow
Facet Joints of the Spine
By Distribution Channel
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Providers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

*** レポート目次(コンテンツ)***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Joint Pain Injections Market, by Region, 2019-2029 (USD Billion)
1.2.2. Joint Pain Injections Market, by Injection Type, 2019-2029 (USD Billion)
1.2.3. Joint Pain Injections Market, by Joint Type, 2019-2029 (USD Billion)
1.2.4. Joint Pain Injections Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Joint Pain Injections Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Joint Pain Injections Market Dynamics
3.1. Joint Pain Injections Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of osteoarthritis and rheumatoid arthritis
3.1.1.2. Growing need for affordable treatment solutions
3.1.1.3. Rising rate of injuries due to accidents
3.1.2. Market Challenges
3.1.2.1. Stringent regularity framework
3.1.3. Market Opportunities
3.1.3.1. Rising geriatric population
3.1.3.2. Growing healthcare infrastructure in developing regions
Chapter 4. Global Joint Pain Injections Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Joint Pain Injections Market, by Injection Type
6.1. Market Snapshot
6.2. Global Joint Pain Injections Market by Injection Type, Performance – Potential Analysis
6.3. Global Joint Pain Injections Market Estimates & Forecasts by Injection Type 2019-2029 (USD Billion)
6.4. Joint Pain Injections Market, Sub Segment Analysis
6.4.1. Interleukin Inhibitors
6.4.2. Hyaluronic Acid Injections
Chapter 7. Global Joint Pain Injections Market, by Joint Type
7.1. Market Snapshot
7.2. Global Joint Pain Injections Market by Joint Type, Performance – Potential Analysis
7.3. Global Joint Pain Injections Market Estimates & Forecasts by Joint Type 2019-2029 (USD Billion)
7.4. Joint Pain Injections Market, Sub Segment Analysis
7.4.1. Knee and Ankle
7.4.2. Hip Joint
7.4.3. Shoulder and Elbow
7.4.4. Facet Joints of the Spine
Chapter 8. Global Joint Pain Injections Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Joint Pain Injections Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Joint Pain Injections Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Joint Pain Injections Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Drug Stores and Retail Pharmacies
8.4.3. Online Providers
Chapter 9. Global Joint Pain Injections Market, Regional Analysis
9.1. Joint Pain Injections Market, Regional Market Snapshot
9.2. North America Joint Pain Injections Market
9.2.1. U.S. Joint Pain Injections Market
9.2.1.1. Injection Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Joint Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Joint Pain Injections Market
9.3. Europe Joint Pain Injections Market Snapshot
9.3.1. U.K. Joint Pain Injections Market
9.3.2. Germany Joint Pain Injections Market
9.3.3. France Joint Pain Injections Market
9.3.4. Spain Joint Pain Injections Market
9.3.5. Italy Joint Pain Injections Market
9.3.6. Rest of Europe Joint Pain Injections Market
9.4. Asia-Pacific Joint Pain Injections Market Snapshot
9.4.1. China Joint Pain Injections Market
9.4.2. India Joint Pain Injections Market
9.4.3. Japan Joint Pain Injections Market
9.4.4. Australia Joint Pain Injections Market
9.4.5. South Korea Joint Pain Injections Market
9.4.6. Rest of Asia Pacific Joint Pain Injections Market
9.5. Latin America Joint Pain Injections Market Snapshot
9.5.1. Brazil Joint Pain Injections Market
9.5.2. Mexico Joint Pain Injections Market
9.5.3. Rest of Latin America Joint Pain Injections Market
9.6. Rest of The World Joint Pain Injections Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AbbVie Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Anika Therapeutics
10.2.3. Bioventus
10.2.4. Eli Lilly and Company
10.2.5. Ferring Pharmaceuticals Inc.
10.2.6. PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.)
10.2.7. Pfizer Inc.
10.2.8. Sanofi S.A.
10.2.9. Teva Pharmaceuticals
10.2.10. Zimmer Biomet
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Joint Pain Injections Market, report scope
TABLE 2. Global Joint Pain Injections Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Joint Pain Injections Market estimates & forecasts by Injection Type 2019-2029 (USD Billion)
TABLE 4. Global Joint Pain Injections Market estimates & forecasts by Joint Type 2019-2029 (USD Billion)
TABLE 5. Global Joint Pain Injections Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Joint Pain Injections Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Joint Pain Injections Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Joint Pain Injections Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Joint Pain Injections Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Joint Pain Injections Market
TABLE 71. List of primary sources, used in the study of global Joint Pain Injections Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BZW23FE0009 )"関節痛用注射のグローバル市場(2022年-2029年):インターロイキン阻害剤、ヒアルロン酸注射" (英文:Global Joint Pain Injections Market Size study & Forecast, by Injection Type (Interleukin Inhibitors, Hyaluronic Acid Injections), by Joint Type (Knee and Ankle, Hip Joint, Shoulder and Elbow, Facet Joints of the Spine), by Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。